openPR Logo
Press release

Flu Treatment Market Size, Development, Demand, Growth and Forecast Report by 2030

03-26-2020 12:52 PM CET | Health & Medicine

Press release from: P&S Intelligence

Flu Treatment Market Size, Development, Demand, Growth

Influenza, shortened to flu, is a fairly common viral infection, affecting millions of people each year. As per the World Health Organization, the disease results in up to 5 million severe cases and 650,000 deaths every year. Most flu symptoms, such as cough (usually dry), fever, muscle and joint pain, headache, sore throat, malaise (feeling unwell), and a runny nose, occur with common cold (rhinitis), which is why doctors often ask patients to go for specific blood tests.

Download sample copy of this report@ https://www.psmarketresearch.com/market-analysis/flu-treatment-market/report-sample

There are four types of influenza viruses: influenza A, influenza B, influenza C, and influenza D. People with uncomplicated flu infections are majorly provided palliative treatment (symptomatic relief), while those with severe infections are given antivirals. Pfizer Inc. Idenix Pharmaceuticals, GlaxoSmithKline PLC, Gilead Sciences, and Bristol-Myers Squibb LLC are the key players in the flu treatment market. Many of the flu drugs have also shown promise in the treatment of coronavirus, which is currently wreaking havoc around the world.

Additionally, the chest X-rays of 91% of favipiravir-treated subjects showed a betterment in lung function, while only 61% of those who weren't given the treatment showed lung condition improvement. Similarly, in the trial being conducted in Wuhan, the drug shortened the duration people had fever to 2.5 days from 4.2 days. Seeing the initial success of favipiravir, several other influenza medicines are expected to be put into COVID-19 trials in the coming months.

Browse full report at@ https://www.psmarketresearch.com/market-analysis/flu-treatment-market

With time, as more favorable results start to emerge from the trials, healthcare facilities around the world, especially those with coronavirus isolation rooms, will start using them in treatment. Ultimately, as more flu drugs prove effective, the demand for these medicines would increase significantly across the globe. Therefore, the growing research and development (R&D) in the healthcare domain, to use influenza drugs in the treatment of coronavirus infection, is helping the flu treatment market advance.

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: http://psintelligence.blogspot.com

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu Treatment Market Size, Development, Demand, Growth and Forecast Report by 2030 here

News-ID: 1985966 • Views: 91

More Releases from P&S Intelligence

More than $15.0 Billion Revenue Expected in Chinese Compressor Market by 2024
The demand for compressors in China is expected to register exponential growth in the coming years, primarily due to the rapid advancements in the country's construction sector. The burgeoning construction activities have contributed toward the rising demand for energy-efficient heating, ventilation, and air-conditioning (HVAC) systems, thereby fuelling the growth in the demand for compressors. Download Brochure With Technical Innovation : https://www.psmarketresearch.com/market-analysis/china-compressor-market/report-sample As per the Council on Tall Buildings and Urban Habitat,
Production Printer Market to Witness a CAGR of 5.1% in Near Future
The demand for personalized solutions is growing across the globe. With the rapidly rising disposable income, people are spending increasingly on products that complement their individual personalities. The major brands are under pressure to provide better experiences to the customers, which is why they are focusing increasingly on enhancing customer engagement, primarily through innovative packaging. Request Sample Copy of Research Report : https://www.psmarketresearch.com/market-analysis/production-printer-market/report-sample Digital printing technology is aiding these companies in offering
Robotic Process Automation Market Analysis, Growth Opportunities and Recent Tren …
Ever since data sharing between two computing devices became possible, cyber-attacks have been leading to huge financial losses all across the world. There are several types of cyber-crimes, such as data and identity theft, email and password hacking, phishing, denial of service (DoS), distributed denial of service (DDoS), and fraudulent transactions. With the increasing awareness of organizations on the issue, they are spending more than before on cyber security. But
How surging in the demand for virtual workforce is driving robotic process autom …
In 2017, the global robotic process automation (RPA) market reached a value of $1,195.9 million and is projected to register a 36.2% CAGR during the forecast period (2018-2023). The market is witnessing growth due to the surging demand for virtual workforce, reduction in workforce cost, greater ease of doing business, and decreasing cost of automation software and services. RPA is a technology that helps in configuring computer software for capturing

All 5 Releases


More Releases for Influenza

Influenza Diagnostics Market – Screening Product Awareness 2025
Global Influenza Diagnostics Market: Snapshot The global market for influenza diagnostics is slated to expand at a promising pace in the next few years as the incidences of influence are rising at a massive pace on the globe front. A common illness of the respiratory system, the condition is responsible for between 250,000 to 500,000 deaths across the globe every year. As the virulent spread of the condition creates increased concerns
Influenza B Infection Market Endeavors Growth 2025
Global Influenza B Infection Market: Snapshot Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Uprising European Influenza Vaccine Market- Ken Research
Europe is at the heart of global vaccine research and production. Influenza is a vaccine preventable disease and influenza vaccine has been available for use in Europe since 1960’s. Approximately, at US$ 1 billion, Europe influenza market was closed. Nevertheless, the highest influenza market share was held by United Kingdom. West Europe has more than US$ 500 Million. United Kingdom, Germany, France, Italy and Spain hold 80 percent of influenza market
Global Influenza Vaccine Market Forecast
Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period. United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine
Influenza Diagnostics Market Analysis – 2024
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about